SHALBY
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
India's Shalby set to rise most in more than 4 months as ICRA reaffirms ratings
** Shalby SHAY.NS jumps 4.6% to 195.4 rupees, on track to log biggest intraday pct gain in more than four months
** Credit rating agency ICRA reaffirms its long-term ratings on the hospital chain operator to A+ and restated outlook to "stable"
** ICRA counts Shalby's strong brand equity across cities, its expansion in new territories and leadership position in the arthroplasty specialty segments as some of its key positives
** ICRA positively factors in increase in footfall of international patients with co's acquisition of Sanar Hospitals, which should start contributing to profits from FY26
** Adds co's ratings also aided by strong operational metrics and positive long-term demand outlook for the Indian healthcare sector
** SHAY down ~19% YTD
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shalby SHAY.NS jumps 4.6% to 195.4 rupees, on track to log biggest intraday pct gain in more than four months
** Credit rating agency ICRA reaffirms its long-term ratings on the hospital chain operator to A+ and restated outlook to "stable"
** ICRA counts Shalby's strong brand equity across cities, its expansion in new territories and leadership position in the arthroplasty specialty segments as some of its key positives
** ICRA positively factors in increase in footfall of international patients with co's acquisition of Sanar Hospitals, which should start contributing to profits from FY26
** Adds co's ratings also aided by strong operational metrics and positive long-term demand outlook for the Indian healthcare sector
** SHAY down ~19% YTD
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
Shalby Says Shalby Hospital Gets Hand Transplant Approval
Feb 11 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY LTD - SHALBY HOSPITAL GETS HAND TRANSPLANT APPROVAL
Source text: ID:nBSE9kljPt
Further company coverage: SHAY.NS
(([email protected];))
Feb 11 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY LTD - SHALBY HOSPITAL GETS HAND TRANSPLANT APPROVAL
Source text: ID:nBSE9kljPt
Further company coverage: SHAY.NS
(([email protected];))
Shalby Says Faces Penalty, Demand Of 62 Mln Rupees
Feb 6 (Reuters) - Shalby Ltd SHAY.NS:
FACES PENALTY, DEMAND OF 62 MILLION RUPEES
Source text: ID:nNSE1FrhNq
Further company coverage: SHAY.NS
(([email protected];;))
Feb 6 (Reuters) - Shalby Ltd SHAY.NS:
FACES PENALTY, DEMAND OF 62 MILLION RUPEES
Source text: ID:nNSE1FrhNq
Further company coverage: SHAY.NS
(([email protected];;))
Shalby Dec-Quarter Consol Net Loss 18.1 Million Rupees
Feb 3 (Reuters) - Shalby Ltd SHAY.NS:
DEC-QUARTER CONSOL NET LOSS 18.1 MILLION RUPEES
DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 2.76 BILLION RUPEES
Source text: ID:nBSE3N0tNZ
Further company coverage: SHAY.NS
(([email protected];))
Feb 3 (Reuters) - Shalby Ltd SHAY.NS:
DEC-QUARTER CONSOL NET LOSS 18.1 MILLION RUPEES
DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 2.76 BILLION RUPEES
Source text: ID:nBSE3N0tNZ
Further company coverage: SHAY.NS
(([email protected];))
India's Shalby gains on US FDA approval for knee replacement device
** Shares of hospital chain operator Shalby SHAY.NS rise as much as 4.9% to 233.65 rupees; currently up 2.6%
** Co on Wednesday said its U.S. unit received U.S. FDA clearance for DuraniomTM, its primary total knee replacement device
** Stock on track for a third consecutive session of gains, if trend holds
** SHAY fell 24.1% in 2024, snapping four straight years of gains
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
** Shares of hospital chain operator Shalby SHAY.NS rise as much as 4.9% to 233.65 rupees; currently up 2.6%
** Co on Wednesday said its U.S. unit received U.S. FDA clearance for DuraniomTM, its primary total knee replacement device
** Stock on track for a third consecutive session of gains, if trend holds
** SHAY fell 24.1% in 2024, snapping four straight years of gains
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
Shalby Ltd Says Shalby Advanced Technologies Gets US FDA Approval For Its Product
Jan 15 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY ADVANCED TECHNOLOGIES GETS US FDA APPROVAL FOR ITS PRODUCT
Source text: [ID:]
Further company coverage: SHAY.NS
(([email protected];;))
Jan 15 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY ADVANCED TECHNOLOGIES GETS US FDA APPROVAL FOR ITS PRODUCT
Source text: [ID:]
Further company coverage: SHAY.NS
(([email protected];;))
Shalby Sept-Quarter Consol Net Profit 33.9 Mln Rupees
Oct 30 (Reuters) - Shalby Ltd SHAY.NS:
SEPT-QUARTER CONSOL NET PROFIT 33.9 MILLION RUPEES
SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.68 BILLION RUPEES
Source text: ID:nNSE1g1Jms
Further company coverage: SHAY.NS
(([email protected];;))
Oct 30 (Reuters) - Shalby Ltd SHAY.NS:
SEPT-QUARTER CONSOL NET PROFIT 33.9 MILLION RUPEES
SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.68 BILLION RUPEES
Source text: ID:nNSE1g1Jms
Further company coverage: SHAY.NS
(([email protected];;))
India's Shalby rises on getting bone bank licence
** Multi-specialty hospital chain operator Shalby SHAY.NS rises as much as 4% to 285.30 rupees
** Co says it received licence from Gujarat government for "performing bone bank" at Krishna Shalby Hospital
** Stock on track to snap 3-session losses
** SHAY last up 3%, cutting YTD losses to 6.7%
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
** Multi-specialty hospital chain operator Shalby SHAY.NS rises as much as 4% to 285.30 rupees
** Co says it received licence from Gujarat government for "performing bone bank" at Krishna Shalby Hospital
** Stock on track to snap 3-session losses
** SHAY last up 3%, cutting YTD losses to 6.7%
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
Shalby Ltd Says Shalby Group Has Received Licence For Performing Bone Bank
Sept 19 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY GROUP HAS RECEIVED LICENCE FOR PERFORMING BONE BANK
Source text for Eikon: ID:nBSE1vFLDS
Further company coverage: SHAY.NS
(([email protected];;))
Sept 19 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY GROUP HAS RECEIVED LICENCE FOR PERFORMING BONE BANK
Source text for Eikon: ID:nBSE1vFLDS
Further company coverage: SHAY.NS
(([email protected];;))
India's Shalby gains on order granting property lease
** Shares of Shalby SHAY.NS rise 4.8% to 299 rupees
** Multi-specialty hospital chain operator granted lease of Asha Parekh Hospital for 30 years
** Order will enable co to expand to Santacruz, Mumbai, by constructing new healthcare facility with over 175 beds
** More than 581,000 shares change hands, 1.7x its 30-day avg
** Stock up 12% so far this year
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
** Shares of Shalby SHAY.NS rise 4.8% to 299 rupees
** Multi-specialty hospital chain operator granted lease of Asha Parekh Hospital for 30 years
** Order will enable co to expand to Santacruz, Mumbai, by constructing new healthcare facility with over 175 beds
** More than 581,000 shares change hands, 1.7x its 30-day avg
** Stock up 12% so far this year
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
Shalby Gets Lease Order On Immoveable Property Of Trust Asha Parekh Hospital For 30 Yrs
July 10 (Reuters) - Shalby Ltd SHAY.NS:
GETS LEASE ORDER ON IMMOVEABLE PROPERTY OF TRUST ASHA PAREKH HOSPITAL FOR 30 YEARS
Source text for Eikon: ID:nNSEch0nl7
Further company coverage: SHAY.NS
(([email protected];))
July 10 (Reuters) - Shalby Ltd SHAY.NS:
GETS LEASE ORDER ON IMMOVEABLE PROPERTY OF TRUST ASHA PAREKH HOSPITAL FOR 30 YEARS
Source text for Eikon: ID:nNSEch0nl7
Further company coverage: SHAY.NS
(([email protected];))
Indian hospital chain operator Shalby down 6% after Q1 profit falls
** Shares of Shalby SHAY.NS fall as much as 6% to 292 rupees, last down 4.2%
** Multi-specialty hospital chain operator reports 20.3% Y/Y fall in Q1 consolidated net profit while rev from ops grew 18.4% Y/Y
** Total expenses rose 24.7%, led by rise in operating expenses
** Stock on track to snap three consecutive sessions of gains, if trend holds
** Trading vol 6.6x 30-day daily avg
** Stock rose 11.6% in June quarter vs fall of 21% in March quarter
** Stock down 1.7% YTD
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
** Shares of Shalby SHAY.NS fall as much as 6% to 292 rupees, last down 4.2%
** Multi-specialty hospital chain operator reports 20.3% Y/Y fall in Q1 consolidated net profit while rev from ops grew 18.4% Y/Y
** Total expenses rose 24.7%, led by rise in operating expenses
** Stock on track to snap three consecutive sessions of gains, if trend holds
** Trading vol 6.6x 30-day daily avg
** Stock rose 11.6% in June quarter vs fall of 21% in March quarter
** Stock down 1.7% YTD
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
Shalby Terminates Franchise Agreement With Madhuban Orthopedic And Multispecialty Surgical Hospital
June 24 (Reuters) - Shalby Ltd SHAY.NS:
TERMINATED FRANCHISE AGREEMENT WITH MADHUBAN ORTHOPEDIC AND MULTISPECIALTY SURGICAL HOSPITAL
Source text for Eikon: ID:nBSE2DdlK8
Further company coverage: SHAY.NS
(([email protected];))
June 24 (Reuters) - Shalby Ltd SHAY.NS:
TERMINATED FRANCHISE AGREEMENT WITH MADHUBAN ORTHOPEDIC AND MULTISPECIALTY SURGICAL HOSPITAL
Source text for Eikon: ID:nBSE2DdlK8
Further company coverage: SHAY.NS
(([email protected];))
Shalby Enters Into Term Loan Agreement
March 14 (Reuters) - Shalby Ltd SHAY.NS:
ENTERED INTO TERM LOAN AGREEMENT TO AVAIL TERM LOAN FACILITY AMOUNTING TO 1 BILLION RUPEES
ENTERED INTO TERM LOAN AGREEMENT WITH BAJAJ FINANCE
Source text for Eikon: ID:nBSE1jbJbq
Further company coverage: SHAY.NS
(([email protected];))
March 14 (Reuters) - Shalby Ltd SHAY.NS:
ENTERED INTO TERM LOAN AGREEMENT TO AVAIL TERM LOAN FACILITY AMOUNTING TO 1 BILLION RUPEES
ENTERED INTO TERM LOAN AGREEMENT WITH BAJAJ FINANCE
Source text for Eikon: ID:nBSE1jbJbq
Further company coverage: SHAY.NS
(([email protected];))
Shalby To Acquire 100% Stake In Healers Hospital
March 12 (Reuters) - Shalby Ltd SHAY.NS:
TO ACQUIRE 100% STAKE IN HEALERS HOSPITAL
TO ACQUIRE 100% STAKE IN HEALERS HOSPITAL FOR ABOUT 1.04 BILLION RUPEES
Source text for Eikon: ID:nBSE67z1Z5
Further company coverage: SHAY.NS
(([email protected];))
March 12 (Reuters) - Shalby Ltd SHAY.NS:
TO ACQUIRE 100% STAKE IN HEALERS HOSPITAL
TO ACQUIRE 100% STAKE IN HEALERS HOSPITAL FOR ABOUT 1.04 BILLION RUPEES
Source text for Eikon: ID:nBSE67z1Z5
Further company coverage: SHAY.NS
(([email protected];))
Shalby Says Unit Got Consultative Letter
Feb 16 (Reuters) - Shalby Ltd SHAY.NS:
UNIT GOT CONSULTATIVE LETTER FOR PAYMENT OF CUSTOMS DUTY OF 158.6 MILLION RUPEES
Source text for Eikon: ID:nNSE9P7sST
Further company coverage: SHAY.NS
(([email protected];;))
Feb 16 (Reuters) - Shalby Ltd SHAY.NS:
UNIT GOT CONSULTATIVE LETTER FOR PAYMENT OF CUSTOMS DUTY OF 158.6 MILLION RUPEES
Source text for Eikon: ID:nNSE9P7sST
Further company coverage: SHAY.NS
(([email protected];;))
Shalby Dec-Qtr Consol Net Profit Rises
Feb 7 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY DEC-QUARTER CONSOL NET PROFIT 190.7 MILLION RUPEES VERSUS PROFIT 152.9 MILLION RUPEES
SHALBY DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 2.16 BILLION RUPEES VERSUS 2.02 BILLION RUPEES
Source text for Eikon: ID:nNSEb2CGnC
Further company coverage: SHAY.NS
(([email protected];;))
Feb 7 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY DEC-QUARTER CONSOL NET PROFIT 190.7 MILLION RUPEES VERSUS PROFIT 152.9 MILLION RUPEES
SHALBY DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 2.16 BILLION RUPEES VERSUS 2.02 BILLION RUPEES
Source text for Eikon: ID:nNSEb2CGnC
Further company coverage: SHAY.NS
(([email protected];;))
Shalby To Acquire Majority Stake In PK Healthcare
Jan 18 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY LTD - TO ACQUIRE MAJORITY STAKE IN PK HEALTHCARE
SHALBY LTD - DEAL FOR 1.02 BILLION RUPEES
Source text for Eikon: ID:nBSE6m8TN7
Further company coverage: SHAY.NS
(([email protected];))
Jan 18 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY LTD - TO ACQUIRE MAJORITY STAKE IN PK HEALTHCARE
SHALBY LTD - DEAL FOR 1.02 BILLION RUPEES
Source text for Eikon: ID:nBSE6m8TN7
Further company coverage: SHAY.NS
(([email protected];))
Shalby Approves Availing Of Enhanced Renewed Sblc Facility Of 1.7 Billion Rupees From ICICI Bank
Dec 12 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY LTD - APPROVED AVAILING OF ENHANCED RENEWED SBLC FACILITY OF 1.7 BILLION RUPEES FROM ICICI BANK
Source text for Eikon: ID:nBSE204jm
Further company coverage: SHAY.NS
(([email protected];;))
Dec 12 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY LTD - APPROVED AVAILING OF ENHANCED RENEWED SBLC FACILITY OF 1.7 BILLION RUPEES FROM ICICI BANK
Source text for Eikon: ID:nBSE204jm
Further company coverage: SHAY.NS
(([email protected];;))
Shalby Says Sushobhan Dasputa, Vice Chairman Will Retire On Account Of Superannuation On Jan 31, 2024
Nov 28 (Reuters) - Shalby Ltd SHAY.NS:
SUSHOBHAN DASPUTA, VICE CHAIRMAN WILL RETIRE ON ACCOUNT OF SUPERANNUATION ON JAN 31, 2024
Source text for Eikon: ID:nNSE7jQGJ4
Further company coverage: SHAY.NS
(([email protected];))
Nov 28 (Reuters) - Shalby Ltd SHAY.NS:
SUSHOBHAN DASPUTA, VICE CHAIRMAN WILL RETIRE ON ACCOUNT OF SUPERANNUATION ON JAN 31, 2024
Source text for Eikon: ID:nNSE7jQGJ4
Further company coverage: SHAY.NS
(([email protected];))
India's Shalby Sept-Quarter Consol Net Profit Rises
Oct 27 (Reuters) - Shalby Ltd SHAY.NS:
SEPT-QUARTER CONSOL NET PROFIT 275.8 MILLION RUPEES VERSUS 184.1 MILLION RUPEES
SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.38 BILLION RUPEES VERSUS 2.02 BILLION RUPEES
Further company coverage: SHAY.NS
(([email protected];))
Oct 27 (Reuters) - Shalby Ltd SHAY.NS:
SEPT-QUARTER CONSOL NET PROFIT 275.8 MILLION RUPEES VERSUS 184.1 MILLION RUPEES
SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.38 BILLION RUPEES VERSUS 2.02 BILLION RUPEES
Further company coverage: SHAY.NS
(([email protected];))
Shalby June-Quarter Consol Net Profit 208.3 Mln Rupees
July 20 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY LTD JUNE-QUARTER CONSOL NET PROFIT 208.3 MILLION RUPEES VERSUS 201.1 MILLION RUPEES
SHALBY LTD JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 2.35 BILLION RUPEES VERSUS 2.02 BILLION RUPEES
Source text for Eikon: ID:nBSE8Cwdqj
Further company coverage: SHAY.NS
(([email protected];))
July 20 (Reuters) - Shalby Ltd SHAY.NS:
SHALBY LTD JUNE-QUARTER CONSOL NET PROFIT 208.3 MILLION RUPEES VERSUS 201.1 MILLION RUPEES
SHALBY LTD JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 2.35 BILLION RUPEES VERSUS 2.02 BILLION RUPEES
Source text for Eikon: ID:nBSE8Cwdqj
Further company coverage: SHAY.NS
(([email protected];))
India's Shalby jumps 8% on signing franchise deal
** Shares of multi-specialty hospital chain operator Shalby SHAY.NS rise as much as 8.03% to 181 rupees, hitting highest level since Oct. 11, 2021
** Co signs agreement with Divine Super Specialty Hospital in Ranchi to set up "franchise‐owned Shalby‐managed" hospital in the region
** Share price above 50-day, 100-day and 200-day simple moving averages, suggesting bullish trend
** SHAY's relative strength index above 70, indicating it is overbought
** More than 702,000 shares traded by 9:52 a.m. IST, 2.2x the 30-day avg
** Stock up 11.1% YTD, as of last close
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
** Shares of multi-specialty hospital chain operator Shalby SHAY.NS rise as much as 8.03% to 181 rupees, hitting highest level since Oct. 11, 2021
** Co signs agreement with Divine Super Specialty Hospital in Ranchi to set up "franchise‐owned Shalby‐managed" hospital in the region
** Share price above 50-day, 100-day and 200-day simple moving averages, suggesting bullish trend
** SHAY's relative strength index above 70, indicating it is overbought
** More than 702,000 shares traded by 9:52 a.m. IST, 2.2x the 30-day avg
** Stock up 11.1% YTD, as of last close
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
India's Shalby Ltd March-Quarter Consol Net Profit Rises
May 18 (Reuters) - Shalby Ltd SHAY.NS:
MARCH-QUARTER CONSOL NET PROFIT 139 MILLION RUPEES VERSUS 102 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.99 BILLION RUPEES VERSUS 1.63 BILLION RUPEES
DIVIDEND IS 1.2 RUPEES PER SHARE
APPOINTS AMIT PATHAK AS CHIEF FINANCIAL OFFICER
VENKAT PARASURAMAN RESIGNS AS CHIEF FINANCIAL OFFICER
Source text for Eikon: [ID:]
Further company coverage: SHAY.NS
(([email protected];))
May 18 (Reuters) - Shalby Ltd SHAY.NS:
MARCH-QUARTER CONSOL NET PROFIT 139 MILLION RUPEES VERSUS 102 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.99 BILLION RUPEES VERSUS 1.63 BILLION RUPEES
DIVIDEND IS 1.2 RUPEES PER SHARE
APPOINTS AMIT PATHAK AS CHIEF FINANCIAL OFFICER
VENKAT PARASURAMAN RESIGNS AS CHIEF FINANCIAL OFFICER
Source text for Eikon: [ID:]
Further company coverage: SHAY.NS
(([email protected];))
Shalby Says Unit Mars Medical Devices Invested $6 Million In Preferred Stock Of Shalby Advanced Technologies
April 27 (Reuters) - Shalby Ltd SHAY.NS:
UNIT MARS MEDICAL DEVICES INVESTED $6 MILLION IN PREFERRED STOCK OF SHALBY ADVANCED TECHNOLOGIES
Further company coverage: SHAY.NS
(([email protected];))
April 27 (Reuters) - Shalby Ltd SHAY.NS:
UNIT MARS MEDICAL DEVICES INVESTED $6 MILLION IN PREFERRED STOCK OF SHALBY ADVANCED TECHNOLOGIES
Further company coverage: SHAY.NS
(([email protected];))
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Shalby do?
Shalby Hospitals is a multispecialty hospital chain in India founded by Dr. Vikram Shah in 1994. With over 2000 hospital beds, it offers a wide range of specialized medical services under one roof, including joint replacement, neurology, cardiology, oncology, and more.
Who are the competitors of Shalby?
Shalby major competitors are Dr Agarwals Eye Hsp, KMC Speciality Hosp, Aashka Hospitals, Artemis Medicare, Fortis MalarHospital, Tejnaksh Healthcare, Global Longlife Hosp. Market Cap of Shalby is ₹1,958 Crs. While the median market cap of its peers are ₹228 Crs.
Is Shalby financially stable compared to its competitors?
Shalby seems to be less financially stable compared to its competitors. Altman Z score of Shalby is 3.27 and is ranked 7 out of its 8 competitors.
Does Shalby pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Shalby latest dividend payout ratio is 15.33% and 3yr average dividend payout ratio is 18.1%
How has Shalby allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery
How strong is Shalby balance sheet?
Balance sheet of Shalby is strong. But short term working capital might become an issue for this company.
Is the profitablity of Shalby improving?
The profit is oscillating. The profit of Shalby is ₹1.92 Crs for TTM, ₹84.08 Crs for Mar 2024 and ₹67.7 Crs for Mar 2023.
Is the debt of Shalby increasing or decreasing?
Yes, The net debt of Shalby is increasing. Latest net debt of Shalby is ₹392 Crs as of Mar-25. This is greater than Mar-24 when it was ₹268 Crs.
Is Shalby stock expensive?
Yes, Shalby is expensive. Latest PE of Shalby is 314, while 3 year average PE is 40.06. Also latest EV/EBITDA of Shalby is 17.72 while 3yr average is 15.57.
Has the share price of Shalby grown faster than its competition?
Shalby has given better returns compared to its competitors. Shalby has grown at ~16.32% over the last 3yrs while peers have grown at a median rate of 11.57%
Is the promoter bullish about Shalby?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Shalby is 74.27% and last quarter promoter holding is 74.27%.
Are mutual funds buying/selling Shalby?
There is Insufficient data to gauge this.